Arena Weighs $10 Stock Scale and 4 Insights to Evaluate Now

Arena Pharmaceutical (NASDAQ:ARNA) increased 0.75% to $10.02 to close today’s abbreviated trading session, with over 15M shares traded, in comparison to its usual volume of 22M shares. In the last year, Arena share prices have seen a low of $1.23 and a high of $13.50, with a current price 708% above that low point, at $10.02. Investors appear mixed at $10 per share for the future potential of the first new diet drug approval in 13 years in Arena’s Lorcaserin.

Don’t Miss: Barclays Chief Quick to EXIT As Probe Deepens

GlaxoSmithKline plc (NYSE:GSK) will pay $3B in criminal and civil fines and plead guilty to misdemeanor criminal charges in regard to the sale and promotion of its antidepressant medications Paxil and Wellbutrin, as well as the diabetes med Avandia, in the biggest health-care fraud settlement in American history. Shares of the drug maker are trading 0.78% lower today.

Sirius XM Radio (NASDAQ:SIRI) reported Tuesday that Academy Award and Grammy winning actor, artist and comedian Jamie Foxx will bring his comedy and entertainment SiriusXM channel The Foxxhole to Atlantic City for the July 4th holiday weekend.

Freeport-McMoRan Copper & Gold (NYSE:FCX): The Phoenix-based mining company will pay $6.8M to address natural resource damages at the Morenci Mine. This settlement will be employed in restoring and rehabilitating natural flora and fauna populations near the Clifton and Morenci communities and the border of New Mexico, according to a representative.

Barclays PLC (NYSE:BCS) CEO and director Bob Diamond has resigned, effective immediately. The search for a new CEO will be led by outgoing chairman Marcus Agius. Shares are trading 2.04% lower today.

Don’t Miss: Here are the STUDS and DUDS of the DOW in 2012.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.